The Cyclooxygenase-2 Inhibitor Nimesulide, a Nonsteroidal Analgesic, Decreases the Effect of Radiation Therapy in Head-and-Neck Cancer Cells
The Cyclooxygenase-2 Inhibitor Nimesulide, a Nonsteroidal Analgesic, Decreases the Effect of Radiation Therapy in Head-and-Neck Cancer Cells
复制标题
DOI:
10.1007/s00066-009-1929-4
复制
发表时间:
2009-05
影响因子:
3.1
通讯作者:
C. Czembirek;C. Eder-Czembirek;B. Erovic;D. Turhani;A. Spittler;E. Selzer;R. Pötter;D. Thurnher
中科院分区:
文献类型:
--
作者:
C. Czembirek;C. Eder-Czembirek;B. Erovic;D. Turhani;A. Spittler;E. Selzer;R. Pötter;D. Thurnher
Background:No data are available on the effects of the cyclooxygenase-2 (COX-2) inhibitor nimesulide in combination with irradiation on the survival of head-and-neck carcinoma cells.Material and Methods:Two head-and-neck carcinoma cell lines (SCC9 and SCC25) were treated with nimesulide (50–600 μM) and irradiated concomitantly or sequentially. Early effects on cell survival were investigated by counting cell numbers, long-term effects by colony-forming assays. Cell-cycle effects were analyzed 24–72 h after treatment with nimesulide by flow cytometry.Results:Unexpectedly, nimesulide solely inhibited cell proliferation without affecting colony-forming ability. In addition, no evidence for a radiosensitizing effect of nimesulide in short-term assays was seen. Nimesulide alone had no effect on clonogenic survival alone or in combination with radiation.Conclusion:Nimesulide differentially affects cell proliferation and clonogenic survival and may decrease the efficacy of radiotherapy. Short-term assays to assess tumor growth may not correctly predict the clinically relevant long-term effect of COX-2 inhibitors.